✦ LIBER ✦

Poly(lactic acid) microspheres for the sustained release of a selective A1 receptor agonist

✍ Scribed by Alessandro Dalpiaz; Angelo Scatturin; Barbara Pavan; Carla Biondi; Maria Angela Vandelli; Flavio Forni

Book ID: 114161163
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 274 KB
Volume: 73
Category: Article
ISSN: 0168-3659
DOI: 10.1016/s0168-3659(01)00293-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Poly(lactic acid) microspheres for the s

Poly(lactic acid) microspheres for the sustained release of antiischemic agents

✍ A Dalpiaz; A Scatturin; B Pavan; C Biondi; M.A Vandelli; F Forni 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 225 KB

Stabilization of tetanus toxoid in poly(

Stabilization of tetanus toxoid in poly(DL-lactic-co-glycolic acid) microspheres for the controlled release of antigen

✍ An-Cheng Chang; Rajesh K. Gupta 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB

In vitro degradation and release behavio

In vitro degradation and release behavior of porous poly(lactic acid) scaffolds containing chitosan microspheres as a carrier for BMP-2-derived synthetic peptide

✍ Xufeng Niu; Qingling Feng; Mingbo Wang; Xiaodong Guo; Qixin Zheng 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 751 KB

The Discovery of Taranabant, a Selective

The Discovery of Taranabant, a Selective Cannabinoid-1 Receptor Inverse Agonist for the Treatment of Obesity

✍ William K. Hagmann 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 817 KB

The Discovery of a Selective, Small Mole

The Discovery of a Selective, Small Molecule Agonist for the Mas-Related Gene X1 Receptor

✍ Wroblowski, Berthold; Wigglesworth, Mark J.; Szekeres, Philip G.; Smith, Graham 📂 Article 📅 2009 🏛 American Chemical Society 🌐 English ⚖ 597 KB

Sustained-release (+)-PHNO [MK-458 (HPMC

Sustained-release (+)-PHNO [MK-458 (HPMC)] in the treatment of Parkinson's disease: Evidence for tolerance to a selective D2-receptor agonist administered as a long-acting formulation

✍ Dr. Jesse M. Cedarbaum; Mary Clark; Linda H. Toy; Alison Green-Parsons 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 683 KB

## Abstract 4‐‐Propyl‐9‐hydroxynaphthoxazine, or MK‐458 (HPMC), a selective, nonergot D2 agonist administered orally twice a day in sustained‐release form, was studied as adjunctive therapy with carbidopa‐levodopa (Sinemet) in 12 Parkinson's disease patients with motor response fluctuations. The do